Peritoneum has an intrinsic fibrinolytic activity that breaks the peritoneal adhesions. Peritoneal injuries with ischemia interfere this fibrinolytic activity and cause adhesions. Pentoxifylline, a methyl xanthine derivative, improves blood flow by decreasing its viscosity and also increases fibrinolytic activity in plasma. We hypothesized that pentoxifylline would increase peritoneal fibrinolysis and ameliorate adhesions. A rat model of peritoneal adhesion (cecal abrasion with gauze, n = 15 for each group) was used to test this hypothesis and cardinal parameters of peritoneal fibrinolysis were measured in peritoneal samples. No medication was given in control animals, while pentoxifylline was administered intraperitonealy (IP) (25 mg/kg, before abdominal closure to whole abdomen) or intravenously (IV) (25 mg/kg, for 9 days after operation) in the experimental groups. At postoperative day 10, peritoneal biopsies were obtained and adhesions were graded qualitatively. Activities and concentrations of tissue plasminogen activator (tPA), plasminogen activator inhibitor type 1 (PAI-1), tPA/PAI-1 complex and hydroxyproline contents were determined. Total adhesion scores were decreased in both treated groups. Mean levels of tPA concentration and tPA activity were increased in the treated groups compared to controls ( p < 0.001 and p = 0.001, respectively). The tPA/PAI-1 complex levels were similar among the three groups. PAI-1 levels were lower in animals receiving IP pentoxifylline compared to control animals and those treated with IV pentoxifylline ( p = 0.048, p = 0.015, respectively). Peritoneal hydroxyproline levels were similar among the three groups. Our results suggest that pentoxifylline administration either through IV or IP may reduce peritoneal adhesion formation probably by altering peritoneal fibrinolytic activity.
1990). Peritoneal adhesions are an unsolved surgical problem. Abdominal operations cause peritoneal injury and ischemia, contamination of foreign body (talk, cotton and starch powder), desiccation and diathermy in peritoneum.
Peritoneal healing differs from that of skin. The two main differences are epithelization and consequences of fibrin deposition. First, the peritoneal epithelization takes place by the entire surface of the defect simultaneously. Skin epithelization results from migration of epithelial cells from dermal edges. Second, fibrin matrix that was formed after peritoneal injury is broken down via peritoneal fibrinolysis and absorbed under normal circumstances. Fibrin matrix is organized to scar tissue in skin healing.
All injuries to the peritoneum lead to the formation of fibrinous exudate, which is essential for normal tissue repair. Such fibrinous material might either reabsorb completely or become organized into fibrous adhesions. The question is what factor determines the reabsorbsion or organization. Ischemia is the most important determinant (Holtz 1984) . If ischemia is absent, epithelization proceeds and fibrin matrix is broken down by fibrinolysis. Normal peritoneum has an inherent fibrinolytic activity. Fibrinolysis is mainly activated by tissue plasminogen activator (tPA) and principal tPA inhibitor is plasminogen activator inhibitor (PAI) type 1. Ischemia reduces fibrinolytic capacity and fibrin matrix changes permanent adhesions (Raftery 1981; Holtz 1984; Menzies 2004) .
Pentoxifylline, a methyl xanthine derivative, enhances plasma fibrinolytic activity, reduces plasma fibrinogen levels, inhibits platelet aggregation and increases erythrocyte and leukocyte flexibility (Jarret et al. 1977; Alkharfy et al. 2000; Schroer 1985) . Eventually, pentoxifylline improves the flow properties of blood by decreasing its viscosity (Jarret et al. 1977; Schroer 1985) . If pentoxifylline increases local (peritoneal) fibrinolytic activity, it possibly reduces peritoneal adhesions. To test this hypothesis, adhesions, fibrinolytic parameters, and hydroxyproline contents of the peritoneal samples were investigated after the pentoxifylline administration in a rat peritoneal adhesion model.
MATERIALS AND METHODS

Animals
The Ethics Committee of Suleyman Demirel University Medical School approved the experimental procedures in this study (Suleyman Demirel University Research Fund, Project Number: 864 M 04) . Animals were obtained from the breeding unit of Suleyman Demirel University, School of Medicine and "All of the guiding principles in the care and use of laboratory animals" were strictly adhered throughout the entire study.
Forty-five female adult Wistar rats weighing 136 -218 g were used. Throughout the experiment, animals were given food and water without any limitation. Animals were assigned in three groups randomly (n = 15 each); control group, intraperitoneal (IP) pentoxifylline group and intravenous (IV) pentoxifylline group.
Anesthesia and experimental design
The rats were anesthetized with 100 mg/kg ketamine hydrochloride (Ketalar ® , Parke -Davis, Morris
Plains, NJ, USA), and 25 mg/kg xylazine hydrochloride (Rompun ® , Bayer, Mefar Ilac Sanayi, Istanbul, Turkey)
intramuscularly. The abdomen was shaved and disinfected with 70% povidone iodine. All surgical procedures were carried out under sterile conditions. After a 3-cm midline incision had been made, antimesenteric border of cecum was abraded with a dry sterile gauze until punctuate bleeding occurred. In control group no medication was given. Abdominal wall was repaired with 2 -0 polypropylene (Prolene ® , Ethicon, Woluwe, Belgium) continuously. In the IP pentoxifylline group pentoxifylline (25 mg/kg; Trental ampul ® , 100 mg/5 ml, Aventis Pharma, Istanbul, Turkey) was administered to the whole abdominal cavity, with 1 : 4 dilution using sterile water (5 ml/kg drug solution). In the IV pentoxifylline group pentoxifylline (25 mg/kg) was administered on a daily basis via the dorsal tail vein, without dilution, from the day of operation, until 9 days postoperatively with the first dose given preoperatively. Abdominal wall was repaired with 2 -0 polypropylene continuously. The skin was closed with 2 -0 polyglactine suture (Vicryl ® , Ethicon, Woluwe, Belgium) continuously. At postoperative day 10, a U-shaped incision was made under the anesthesia that was described previously. Adhesions were classified into four groups according to their severity (Evans et al. 1993) (Table 1) .
Peritoneal biopsy specimens were taken from the right lower quadrant while the animals were alive. Biopsy specimens were rinsed with normal saline solution and dried with a piece of blotting paper to remove blood. The biopsy specimens were stored at -80°C in airtight tubes until the homogenization.
Homogenization
For the homogenization of the biopsy specimens, 1 ml homogenizing solution (0.1% Tritron X 100, 2.5 mM sodium dihydrogen phosphate, 0.075 M sodium chloride) was added for every 40 mg tissue. After the biopsy specimens were homogenized in an Ultra Thurrax IKA T -25 (Janke & Kunken, Staufen, Germany) homogenizer for 3 min, the homogenates were sonicated (Bandelin Electronic, Berlin, Germany) for 30 sec. The homogenates were centrifuged at 4,000 g for 20 min and supernatants were stored at -80°C until assay. (Woessner 1961) .
The protein contents of the supernatants were assayed with Lowry method. tPA, tPA activity, PAI-1 and tPA/PAI-1 complex concentrations were normalized with the protein contents in the supernatants. The results of tPA, PAI-1 and tPA/PAI-1 complex parameters were described as ng/mg protein and tPA activity as IU/mg protein.
Statistical analysis
Results are given as mean ± S.D. Mann Whitney's U-test was used to compare the adhesion grades in groups. Mann Whitney's U-test was also used to determine the significance of differences in the hydroxyproline content and normalized values of tPA, tPA activity, PAI-1 and tPA/PAI-1 complex assays. P < 0.05 was considered significant. The statistical analysis was performed by using the Statistical Package for Social Sciences (SPSS for Windows Release 10.0, Chicago, IL, USA).
RESULTS
Adhesion formation
The adhesion grades were significantly lower in IP (0.80 ± 0.77) and IV pentoxifylline groups (1.07 ± 0.80) than the control group (2.0 ± 0.76) ( p = 0.001 and p = 0.006 respectively, Fig. 1 ). Adhesion scores tended to be lower in IP pentoxifylline than the IV pentoxifylline group, but the difference was not significant ( p = 0.353) (Fig. 1) .
tPA
In both IP (21.72 ± 11.09 ng/mg protein) and IV (21.60 ± 12.18 ng/mg protein) pentoxifylline groups, tPA levels were twofold higher in peritoneal samples compared with the control group (9.61 ± 4.22 ng/mg protein) ( p < 0.001 and p = 0.001, respectively). No significant differences were encountered in tPA levels regarding the route of pentoxifylline administration ( p = 0.723) (Table 2, Fig. 2 ). 
tPA activity
The levels of tPA activity were found higher in IP (53.85 ± 10.33 IU/mg protein) and IV (41.58 ± 10.85 IU/mg protein) pentoxifylline groups than the control group (30.58 ± 7.14 IU/mg protein) ( p < 0.001, p = 0.003, respectively). On the other hand, mean tPA activity was higher in animals receiving IP pentoxifylline compared to animals receiving IV pentoxifylline ( p = 0.005) ( Table 2 , Fig. 3 ).
PAI-1
While PAI-1 levels in IP pentoxifylline group (5.74 ± 9.11 ng/mg protein) were lower than the control group (17.8 ± 19.35 ng/mg protein) ( p = 0.048), there was no significant difference Mann Whitney's U-test was used to determine the significance of differences in the normalized values of tPA, tPA activity, PAI-1 and tPA/PAI-1 complex assays and HP contents.
a Results are mean ± S.D.
b P values are concerning about the comparisons between control and experimental groups. between IV pentoxifylline (11.42 ± 8.34 ng/mg protein) and control group ( p = 0.739). PAI-1 levels differed significantly among the IP and IV pentoxifylline groups ( p = 0.015) ( Table 2 , Fig. 4 ).
tPA/PAI-1 complex
There were no differences in the levels of tPA/PAI-1 complex between the control group (6.50 ± 2.28 ng/mg protein) and both IP (6.32 ± 1.17 ng/mg protein) and IV (5.62 ± 0.59 ng/mg protein) pentoxifylline group ( p = 0.819 and p = 0.109). However, tPA/PAI-1 complex levels were slightly lower in IP pentoxifylline group than IV pentoxifylline group ( p = 0.043) (Table 2, Fig. 5 ).
Hydroxyproline
Peritoneal hydroxyproline measurements did not differ significantly among the groups ( p = 0.269, p = 0.755, p = 0.128, respectively) ( Table  2) .
DISCUSSION
Present investigation demonstrated that IP and IV administrations of pentoxifylline reduced peritoneal adhesion formation. Higher tPA and tPA activity levels and lower PAI-1 levels in experimental groups indicate that both application manners improved fibrinolysis within the peritoneum. The improvement was more prominent in IP pentoxifylline group (Figs. 1 -5 ). Although adhesion scores were slightly lower in the IP pentoxifylline group than the IV pentoxifylline group, this was not statistically different. Pentoxifylline did not change hydroxyproline Values are median (horizontal bars), with interquartile range (boxes) and 10 -90th centile (error bars). Mann Whitney's U-test was used. levels of peritoneum in our study.
Several animal experiments proved satisfactory results in pentoxifylline administration to the peritoneal adhesions prevention (Chalkiadakis et al. 1985; Steinleitner et al. 1990; Lai et al. 1994; Kaleli et al. 1998) . In a peritonitis model, which was induced in rats by creating a closed ileal loop, 30 -day intramuscular pentoxifylline administration increased the survival of animals and reduced adhesion and abscess formation (Chalkiadakis et al. 1985) . Steinleitner et al. (1990) demonstrated a marked inhibition of adhesion reformation after lysis of pelvic adhesions in rabbit uterine horn model with the three-day subcutaneous pentoxifylline treatment. In an another experimental rat model of intestinal resection and reanastomosis, IP pentoxifylline irrigation and irrigation plus 14 day intramuscular pentoxifylline injection resulted significantly and equally reduced adhesion at the anastomotic site (Lai et al. 1994) . Kaleli et al. (1998) reported that the IP application of L-arginine and pentoxifylline reduced adhesion formation equally in rat uterine horn model.
Data from these studies showed that both IP and systemic pentoxifylline administration reduced the development of adhesions. However, the effects of pentoxifylline on peritoneal fibrinolysis were not investigated so far. Our model confirmed and extended these findings. Ivarsson et al. (1998) suggested that there was covariance in the levels of PAI-1 and tPA/PAI-1 complex, because PAI-1 inhibits fibrin degradation by forming inactive complexes with plasminogen activators. However, there was no parallelism or connection between the levels of tPA/PAI-1 complexes and other peritoneal fibrinolytic parameters among the three groups in our study.
Numerous agents have been used to reduce postoperative adhesions. Seprafilm is such a commercially available material. The safety and efficacy of this membrane in preventing postoperative adhesion has been demonstrated in clinical and experimental studies (Becker and Dayton 1996; Kelekci et al. 2004) . It was pointed out that Seprafilm had no major effect on peritoneal fibrinolysis but it increased peritoneal hydroxyproline (Altuntas et al. 2002; Tarhan et al. 2005) .
A drawback of our experimental design could be the lack of application of sterile water to the control animals. We were not able to locate any data in the literature about the effectivity of sterile water in peritoneal adhesions. However, it seems unlikely that the reduction in peritoneal adhesions is solely attributable to sterile water rather than pentoxifylline.
We conclude that adhesion preventive effects of pentoxifylline administration may result from its positive effects on peritoneal fibrinolysis.
